India Made Covaxin Effective Against Delta Plus Variant, Says ICMR Study
Covaxin, India’s first indigenous vaccine to fight Covid-19, is effective against the Delta Plus variant of coronavirus, a study conducted by Indian Council of Medical Research (ICMR) has said, according to news agency ANI. Covaxin has been developed by Bharat Biotech, in collaboration with ICMR.